About AllCells
AllCells is a company based in Alameda (United States) founded in 1998 was acquired by Discovery Life Sciences in July 2022.. The company has 58 employees as of December 31, 2022. AllCells offers products and services including Leukopak, Cryopreserved Leukopak, Bone Marrow, and Cord Blood. AllCells operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Alameda, United States
- Employees 58 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Allcells Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$220.31 K (USD), Grant
Sep 15, 2015
-
Investors
HHS
& 1 more
-
Employee Count
58
as on Dec 31, 2022
-
Acquired by
Discovery Life Sciences
(Jul 12, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AllCells
AllCells offers a comprehensive portfolio of products and services, including Leukopak, Cryopreserved Leukopak, Bone Marrow, and Cord Blood. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers large-scale yield of CD34+ cells for research purposes.
Provides preserved cells for cell and gene therapy studies.
Supplies fresh aspirate for hematological research applications.
Delivers CD34+ cells from donors for therapy development.
Unlock access to complete
Funding Insights of AllCells
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $220,314
-
First Round
First Round
(15 Sep 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2015 | Amount | Grant - AllCells | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in AllCells
AllCells has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Discovery Life Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Provider of diversified services with integrated technology platforms for drug discovery
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by AllCells
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - AllCells
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Allcells Comparisons
Competitors of AllCells
AllCells operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Allcells
Frequently Asked Questions about AllCells
When was AllCells founded?
AllCells was founded in 1998 and raised its 1st funding round 17 years after it was founded.
Where is AllCells located?
AllCells is headquartered in Alameda, United States. It is registered at Alameda, California, United States.
How many employees does AllCells have?
As of Dec 31, 2022, the latest employee count at AllCells is 58.
What does AllCells do?
AllCells was founded in 1998 and is based in Alameda, United States. Primary cells from human and animal sources, including stem cells derived from bone marrow, peripheral blood, mobilized peripheral blood, cord blood, diseased tissues, and non-human primates, are supplied by the company. Associated media, cytokines, reagents, and biological research services are also offered within the biotechnology sector focused on cell-based research.
Who are the top competitors of AllCells?
AllCells's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does AllCells offer?
AllCells offers Leukopak, Cryopreserved Leukopak, Bone Marrow, and Cord Blood.
Who are AllCells's investors?
AllCells has 2 investors. Key investors include HHS, and Discovery Life Sciences.